Article
Metabolic profiling and cytochrome P450 reaction phenotyping of medroxyprogesterone acetate.
Drug metabolism and disposition: the biological fate of chemicals - 1 Nov 2008
Zhang Jiang-Wei, Liu Yong, Zhao Jiu-Yang, Wang Li-Ming, Ge Guang-Bo, Gao Yang, Li Wei, Liu Hong-Tao, Liu Hui-Xin, Zhang Yan-Yan, Sun Jie, Yang Ling
Abstract excerpt
Medroxyprogesterone acetate (MPA) is one of the most frequently prescribed progestins for conception, hormone replacement therapy, and adjuvant endocrine therapy. MPA has a low oral bioavailability because of extensive metabolism; however, its metabolism was poorly documented. This study was intended to profile the phase I metabolites of MPA and the cytochrome P450 (P450) isoforms involved. After MPA was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
